Welcome to the 4th Pharmacovigilance and Drug Safety Conference, taking place on June 29-30 in Barcelona! Dive into two days of impactful discussions, interactive roundtables, and thought-provoking keynote speeches from industry leaders. This year, we’ll explore trending topics including AI-driven pharmacovigilance, predictive analytics for adverse event detection, automation in drug safety reporting, real-world evidence and its role in pharmacovigilance, machine learning applications in signal detection, and global regulatory challenges in the evolving safety landscape.
Join us in the vibrant city of Barcelona for an unparalleled experience. Mark your calendars for June 29th and 30th!
Director, Head of Pharmacovigilance (UK) at Ipsen
Pav Rishiraj, Director, Head of Pharmacovigilance (UK) at Ipsen is speaking at the 4th Pharmacovigilance & Drug Safety Conference in Barcelona on 29&30 April 2025.
Pav Rishiraj
Director, Head of Pharmacovigilance (UK)
Ipsen
Senior Director, Devices & Digital Safety at AstraZeneca
James Whitehead, Senior Director, Devices & Digital Safety at AstraZeneca is speaking at the 4th Pharmacovigilance & Drug Safety Conference in Barcelona on 29&30 April 2025.
James Whitehead
Senior Director, Devices & Digital Safety
AstraZeneca
PV Country Head Germany and Deputy EU QPPV, Bayer
I used to write about my skills, now I would rather tell you about my passions: I am passionate about Patient Safety, and helping people become their best selves. Great communicator in several languages, with a love of arts and food from all around the world. My greatest assets are being empathetic, good humored and not being afraid of changes. Oh yes, and I do bring over 15 years of pharmacovigilance and leadership experience to the table, in various local and global functions. I am currently working at Bayer, as PV Country Head in Germany and being the Deputy EU QPPV.
Yvonne Nanciu
PV Country Head Germany and Deputy EU QPPV Bayer
Head, Global Clinical Quality & Pharmacovigilance, Insud Pharma
Jorgen Matz, Head, of Global Clinical Quality & Pharmacovigilance, Insud Pharma is speaking at the 4th Pharmacovigilance & Drug Safety Conference in Barcelona on 29&30 April 2025.
Jorgen Matz
Head, of Global Clinical Quality & Pharmacovigilance
Insud Pharma
Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories
Balaji Sainath Malla, Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories is speaking at the 4th Pharmacovigilance & Drug Safety Conference in Barcelona on 29&30 April 2025.
Balaji Sainath Malla
Head of Pharmacovigilance, QPPV- EU & UK
Dr. Reddy's Laboratories
Medical Safety Lead, Sandoz
EU/UK QPPV, Head Regional Pharmacovigilance, Glenmark Pharmaceuticals
Learn from Dr. Dnyaneshwar Sanap, EU/UK QPPV, Head Regional Pharmacovigilance from Glenmark Pharmaceuticals, speaking at the 3rd Pharmacovigilance & Drug Safety Conference in Lisbon on 6 & 7 June.
Dr. Dnyaneshwar Sanap
EU/UK QPPV, Head Regional Pharmacovigilance Glenmark
Head of Patient Safety at Bristol-Myers Squibb
Learn from Lídia Vieira from BMS, presenting at the 3rd Pharmacovigilance and Drug Safety Conference in Lisbon, 6-7 June.
Lídia Vieira
Head of Patient Safety
Bristol-Myers Squibb
Senior Director Pharmacovigilance, QPPV, Shionogi
Pharmacist as background, Valentina is currently “Senior Director Pharmacovigilance, QPPV” at Shionogi and responsible for PV system implementation in EEA and in UK. Previous experiences include Pfizer, Takeda and Baxter, with increasing responsibilities in Pharmacovigilance and additional experience as clinical QA and Medical information.
Valentina is a member of Transcelerate and a lecturer in academic post-graduate courses. She has great consideration of business network and valuable professional relationships, attending several congresses and seminars as a speaker and being part of scientific societies working groups and pharma industry associations.
Valentina Mancini
Senior Director Pharmacovigilance, QPPV
Shionogi
PV Country Head Germany and Deputy EU QPPV, Bayer
I used to write about my skills, now I would rather tell you about my passions: I am passionate about Patient Safety, and helping people become their best selves. Great communicator in several languages, with a love of arts and food from all around the world. My greatest assets are being empathetic, good humored and not being afraid of changes. Oh yes, and I do bring over 15 years of pharmacovigilance and leadership experience to the table, in various local and global functions. I am currently working at Bayer, as PV Country Head in Germany and being the Deputy EU QPPV.
Yvonne Nanciu
PV Country Head Germany and Deputy EU QPPV Bayer
Associate Director, Consumer Safety Science, Haleon
Epidemiologist by training with experience both in communicable an non-communicable diseases. Drug safety and risk management professional with almost 13 years of experience in the pharmaceutical industry. My previous experience including a nongovernmental organization board representative, an academic lecturer, and a state epidemiologist resulted in the development of capacities and skills such as project management, conduct of applied research projects and protocol development, data management, public speaking, development and improvement of the educational and training materials. Experienced in people management.
Agnieszka Kicman-Gawłowska
Associate Director, Consumer Safety Science
Haleon
Safety risk Lead Director, Pfizer
Learn from Maria Maddalena Lino, Safety Risk Lead Director, Pfizer presenting at the 3rd Pharmacovigilance and Drug Safety Conference in Lisbon, 6-7 June 2024.
Maria Maddalena Lino
Safety Risk Lead Director
Pfizer
Patient Safety Cluster Lead - Middle East and Turkey / Global patient Safety Evaluation
Learn from Raghda Mohamed from Takeda at the 3rd Pharmacovigilance and Drug Safety Conference in Lisbon.
Raghda Mohamed
Patient Safety Cluster Lead - Middle East and Turkey / Global Patient Safety Evaluation
Takeda
EMEA IPV Affairs Regional Lead at Johnson & Johnson
I am a graduate in Pharmaceutical Sciences from Lisbon University and I have recently concluded an Executive Program, Leading Pharma at Católica-Lisbon. I have 13 years of experience in the pharmaceutical industry, handling different responsibilities in Regulatory Affairs, Pharmacovigilance and Medical Information, and have been involved in many local and international projects and working groups related to my areas of expertise. Additionally, I am skilled in training, public speaking, epidemiology, leadership, negotiation. Areas related to patient safety, public and policy health and communication are a real interest to me. I am passionate for everything that can contribute to the safe use of medicines and all strategic solutions that help to preserve and promote the health and well-being of populations and communities. I’m keen on continuous creative learning, thus enabling the use of all the tools necessary to achieve correctly my professional and personal objectives.
Isa Costa
EMEA IPV Affairs Regional Lead
Johnson & Johnson
President, Focused Consulting, Staffing, & Drug Safety, LLC
Learn from Michael Kieffer at the 3rd Pharmacovigilance and Drug Safety Conference in Lisbon, 6-7 June.
Michael Kieffer
President
Focused Consulting, Staffing, & Drug Safety, LLC
Regional Patient Safety & Pharmacovigilance Lead for India, Middle East, Turkey & Africa, Boehringer Ingelheim
Dr. Zakaria holds a Doctoral degree in pharmacy from Algeria and a Pharmacovigilance certificate from France.
He started his career in Pharmacovigilance at Roche Pharmaceutical, where he has also served in different roles in Medical Affairs and Products Quality.
Dr. Zakaria joined Boehringer Ingelheim in February 2019 as the Local Pharmacovigilance Manager for the North-West Africa Region and is currently the regional Pharmacovigilance Lead for the IMETA region (India, Middle East, Turkey, and Africa) based in Dubai-UAE.
Dr. Zakaria Thamri
Regional Patient Safety & Pharmacovigilance Lead for India, Middle East, Turkey & Africa
Boehringer Ingelheim
Vice President, Managing Director Integrated Safety, IQVIA
Gurpreet Singh is currently the Vice President, Managing Director Integrated Safety at IQVIA. He is based in UK and has a total of 18 years' experience in Pharma Industry of which 16+ years have been in Global Drug Development.
During these years he has had the opportunity to work with some top Global companies like Cognizant, Tata Consultancy, Novartis and Parexel. At Novartis he was the Global Head of PV Operations managing all Global PV activities. At Parexel he was the Senior Director PV Operations responsible for managing PV projects of top Global Pharma and Biotech companies.
Gurpreet is a certified Six Sigma and Project Management Professional. He has keen interest in Digital Transformation and Organization Culture and has successfully led various projects during his tenure in the Pharma Industry. He is an avid runner and a speaker at various Pharma conferences.
Gurpreet Singh
Vice President, Managing Director Integrated Safety
IQVIA
Name: André Prado
Phone: +351 926 623 972
Email: andre.prado@ubiqevents.com
Name: Vladka Roriz
Phone: +421 902 161 667
Email: vladka.roriz@ubiqevents.com
Taxi, Uber, or Bolt – 15 min (15 €)
Committed to Life Sciences!
Karpatské námestie 10A, 831 06 Bratislava – Slovakia
@ UBIQ events is part of UBIQ events, s. r. o. registered in Slovakia, Spain and Portugal.
©2024 UBIQ events - All Rights Reserved
